Mesalamine suppository

Details Mesalamine suppository Mesalamine suppository

2008-10-03

2009-06-02

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S159000, C514S567000, C514S953000, C424S433000

Reexamination Certificate

active

07541384

ABSTRACT:
The present invention relates to a mesalamine rectal suppository designed to provide improved comfort of use. One embodiment of the invention is a mesalamine rectal suppository containing mesalamine and one or more pharmaceutically acceptable excipients, wherein the drug load of the suppository ranges from 35% to 50%. Another embodiment of the invention is a mesalamine rectal suppository containing from about 850 to about 1150 mg mesalamine and one or more pharmaceutically acceptable excipients, wherein the total weight of the suppository ranges from about 2250 to about 2700 mg. Yet another embodiment of the invention is a mesalamine rectal suppository comprising mesalamine having a tap density ranging from about 600 to about 800 g/L (as measured by USP <616>) and a hard fat having an ascending melting point of 32 to 35.5° C. Methods of preparing and methods of treatment with mesalamine suppositories are also provided. The invention further provides a method of determining a dissolution parameter (such as dissolution rate) of a mesalamine rectal suppository, such as a 1 g mesalamine suppository, by measuring its dissolution with USP Apparatus #2 at 40° C. and a paddle rotation speed of 125 rpm in 0.2 M phosphate buffer at a pH of 7.5.

REFERENCES:
patent: 3689514 (1972-09-01), Neissner et al.
patent: 4211777 (1980-07-01), Chambers et al.
patent: 4298595 (1981-11-01), Parkinson et al.
patent: 4374932 (1983-02-01), Pitzele et al.
patent: 4540685 (1985-09-01), Bauer et al.
patent: 4632921 (1986-12-01), Bauer et al.
patent: 4699902 (1987-10-01), Bauer et al.
patent: 5500221 (1996-03-01), Murata et al.
patent: 5508037 (1996-04-01), ElSohly
patent: 5539000 (1996-07-01), Leonard
patent: 5629012 (1997-05-01), Halskov et al.
patent: 5716648 (1998-02-01), Halskov et al.
patent: 6136337 (2000-10-01), Kondo et al.
patent: 6139863 (2000-10-01), Yokomachi et al.
patent: 6210698 (2001-04-01), Yamazaki et al.
patent: 6326364 (2001-12-01), Lin et al.
patent: 6720001 (2004-04-01), Chen et al.
patent: 6903082 (2005-06-01), Ekwuribe et al.
patent: 7250445 (2007-07-01), Ehrenpreis
patent: 7312243 (2007-12-01), Pravda
patent: 7326809 (2008-02-01), Wallace et al.
patent: 7341741 (2008-03-01), Sachetto et al.
patent: 2002/0037855 (2002-03-01), Stanislaus
patent: 2005/0159396 (2005-07-01), Harty
patent: 2006/0003972 (2006-01-01), Wallace et al.
patent: 2006/0127503 (2006-06-01), Harly
patent: 2006/0223787 (2006-10-01), Devane et al.
patent: 2007/0122384 (2007-05-01), Ohrstrom
patent: 2007/0167416 (2007-07-01), Johnson
patent: 2007/0213296 (2007-09-01), Zhang
patent: 2007/0240236 (2007-10-01), Xia
patent: 2007/0254050 (2007-11-01), Quart et al.
patent: 2008/0008740 (2008-01-01), Franc et al.
patent: 2008/0020018 (2008-01-01), Moodley et al.
patent: 2008/0031983 (2008-02-01), Quart et al.
patent: 2008/0076744 (2008-03-01), Schreiber
patent: 2008/0107650 (2008-05-01), Tartaglia et al.
patent: 2008-024713 (2008-02-01), None
Marteau et al. Gut, 1998, vol. 42, No. 2, pp. 195-199.
Hanauer et al. Abstract, American Journal of Gastroenterology, vol. 95, No. 7, pp. 1749-1754 (2000).
Physicians Desk Reference (1999) for Rowasa® pp. 3126-3128.
CANASA® Package Insert, Axcan Proposed Nov. 4, 2004.
Zhongguo Linchuang Yaolixue Zazhi, vol. 20, No. 2, pp. 126-130 (2004).
MacDermott, R. P., J Gastroenterology, 31:907:-916 (1996).
Mesalamine Suppositories; www.drugs.com/cdi/mesalamine-suppositories.html; Accessed Jun. 2, 2008.
Declaration of David R. Powell, Ph.D.

Affiliated with

Also associated with

Rating

Mesalamine suppository does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mesalamine suppository, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mesalamine suppository will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4122292